|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 December 2000, Vol. 96, No. 13, pp. 4118-4123
HEMATOPOIESIS
Evidence that ceramide mediates the ability of tumor necrosis
factor to modulate primitive human hematopoietic cell fates
Veronique Maguer-Satta,
Robert Oostendorp,
Dianne Reid, and
Connie J. Eaves
From the Terry Fox Laboratory, British Columbia Cancer
Agency, Vancouver, BC, Canada.
In this study, it is shown that short-term exposure of normal human
marrow CD34+CD38 cells to low concentrations
of tumor necrosis factor (TNF) in the presence of 100 ng/mL Flt3 ligand
and Steel factor and 20 ng/mL interleukin-3 (IL-3), IL-6, and
granulocyte colony-stimulating factor, in either bulk or single-cell
serum-free cultures, markedly reduces their ability subsequently to
generate colony-forming cells (CFCs) in 6-week stromal cell-containing
long-term cultures without affecting their viability, mitogenic
response, or short-term ability to produce CFCs. A similar differential
effect on the functional attributes of
CD34+CD38 cells was seen when C2- or
C6-ceramide, but not dihydro-C2-ceramide (an inactive analog of
ceramide), was substituted for TNF. The addition of D-erythro-MAPP (a
specific inhibitor of intracellular ceramide degradation) enhanced the
ability of TNF to selectively eliminate long-term culture-initiating
cell (LTC-IC) activity. These findings indicate that TNF can directly
modulate the ability of CD34+CD38 cells to
maintain their LTC-IC function at doses below those required to
initiate apoptosis, cell cycle arrest, or both, and they suggest that
this may be mediated by the TNF-induced generation of intracellular
ceramide. Identification of a signaling intermediate that can influence
primitive hematopoietic cell fate decisions offers a new approach to
the investigation of signaling mechanisms in normal stem cell
populations and to how these may be altered in leukemic cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Rezzoug, Y. Huang, M. K. Tanner, M. Wysoczynski, C. L. Schanie, P. M. Chilton, M. Z. Ratajczak, I. J. Fugier-Vivier, and S. T. Ildstad
TNF-{alpha} Is Critical to Facilitate Hemopoietic Stem Cell Engraftment and Function
J. Immunol.,
January 1, 2008;
180(1):
49 - 57.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Franchi, F. Malisan, B. Tomassini, and R. Testi
Ceramide catabolism critically controls survival of human dendritic cells
J. Leukoc. Biol.,
January 1, 2006;
79(1):
166 - 172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Vas, R. Fajka-Boja, G. Ion, V. Dudics, E. Monostori, and F. Uher
Biphasic Effect of Recombinant Galectin-1 on the Growth and Death of Early Hematopoietic Cells
Stem Cells,
February 1, 2005;
23(2):
279 - 287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen
IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
J. Immunol.,
January 15, 2005;
174(2):
752 - 757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Bunting
ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells
Stem Cells,
January 1, 2002;
20(1):
11 - 20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dybedal, D. Bryder, A. Fossum, L. S. Rusten, and S. E. W. Jacobsen
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
Blood,
September 15, 2001;
98(6):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Audet, C. L. Miller, S. Rose-John, J. M. Piret, and C. J. Eaves
Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
PNAS,
February 13, 2001;
98(4):
1757 - 1762.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
